If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.71    0.11 (6.87%)
Bid:
1.61
Ask:
1.72
Spread: 0.11 (6.832%)
Market Cap: £34.31m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Marine Project Update

10 Jul 2024 07:00

RNS Number : 7658V
Quadrise PLC
10 July 2024
 

10 July 2024

Quadrise Plc ("Quadrise" or the "Company")

Marine Project Update

Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its project with MSC Shipmanagement Limited of Cyprus ("MSC").

Quadrise continues to work with MSC and project counterparties to conclude the binding agreement between Quadrise, MSC and Cargill in respect of Company's forthcoming vessel trials on board the MSC Leandra (the "Project Agreement").

Upon signing the Project Agreement, Quadrise equipment will be installed and commissioned at the MAC² facility in Antwerp prior to vessel trials. MAC² has already received the required operating permits for the installation of Quadrise equipment and has prepared the site ahead of time, therefore we are ready to move quickly once the Project Agreement is finalised.

Quadrise will provide a further update on the MSC vessel trial timetable following signature of the Project Agreement.

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

"We continue to have regular contact with MSC and other project counterparties and are preparing for installation of our equipment to commence as soon as the agreement is signed.."

 

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

Joint Brokers

Shore Capital Stockbrokers Limited

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

+44 (0)20 7408 4090

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Cutbill Jacoby

Andy Cutbill

Georgie Cutbill

 

+44 (0)7841 576000

+44 (0)7850 195353

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X (formerly Twitter): @QuadrisePlc

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFEIDTIAIIS
Date   Source Headline
24th May 20127:02 amRNSBoard Changes
24th May 20127:00 amRNSFinal Results - Part 2
24th May 20127:00 amRNSFinal Results - Part 1
23rd May 20127:00 amRNSiQ Fund agrees further £70m financing with M&G
15th May 20123:23 pmRNSDirector/PDMR Shareholding
14th May 201210:52 amRNSNotice of Preliminary Results
4th May 20124:02 pmRNSDirector/PDMR Shareholding
30th Apr 201210:35 amRNSBlocklisting Interim Review
3rd Apr 20127:00 amRNSiQ Fund Agrees £158 million refinancing
2nd Apr 201210:32 amRNSTotal Voting Rights
29th Mar 20127:00 amRNSSale of Emersons Green
23rd Mar 201210:58 amRNSDirector/PDMR Shareholding
29th Feb 20124:54 pmRNSTotal Voting Rights
28th Feb 20127:00 amRNSAcquisition
20th Feb 20121:32 pmRNSHolding(s) in Company
16th Feb 20122:44 pmRNSDirectorate Change
2nd Feb 20127:00 amRNSInterim Management Statement
1st Feb 20122:30 pmRNSNotice of IMS
31st Jan 20125:44 pmRNSTotal Voting Rights
17th Jan 201211:04 amRNSDirector/PDMR Shareholding
29th Dec 201110:22 amRNSTotal Voting Rights
13th Dec 20113:33 pmRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSHalf Yearly Report
22nd Nov 20112:55 pmRNSHolding(s) in Company
17th Nov 20117:00 amRNSDisposal
14th Nov 20112:20 pmRNSDirector/PDMR Shareholding
4th Nov 20114:04 pmRNSHolding(s) in Company
1st Nov 201110:27 amRNSBlocklisting Interim Review
20th Oct 20112:43 pmRNSNotice of Results
18th Oct 201110:03 amRNSAdditional Listing
13th Oct 20112:34 pmRNSDirector/PDMR Shareholding
13th Oct 20117:00 amRNSDisposal
11th Oct 201110:03 amRNSHolding(s) in Company
10th Oct 20111:10 pmRNSHolding(s) in Company
22nd Sep 20112:30 pmRNSDirector/PDMR Shareholding
21st Sep 20118:30 amRNSHolding(s) in Company
19th Sep 20111:53 pmRNSHolding(s) in Company
16th Sep 20114:57 pmRNSDirector/PDMR Shareholding
6th Sep 20114:31 pmRNSAnnual Information Update
5th Sep 20114:01 pmRNSResult of AGM
31st Aug 20115:20 pmRNSHolding(s) in Company
16th Aug 20111:09 pmRNSDirector/PDMR Shareholding
11th Aug 201110:26 amRNSNotice of AGM
10th Aug 20117:00 amRNSInterim Management Statement
1st Aug 20113:14 pmRNSNotice of IMS
14th Jul 201112:08 pmRNSAnnual Financial Report
13th Jul 20113:10 pmRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSDirectorate Change
14th Jun 201111:18 amRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.